Ergot-derivative Dopamine Receptor Agonists
- Name
- Ergot-derivative Dopamine Receptor Agonists
- Accession Number
- DBCAT003643
- Description
Not Available
- Drugs
Drug Drug Description Cabergoline A dopamine receptor agonist used for the treatment of hyperprolactinemic conditions due to various causes. Bromocriptine A dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome. Pergolide A long-acting dopamine agonist that is uncommonly used for the management of Parkinson's disease, due to the risk for cardiac valvulopathy. Dihydroergocryptine A dopamine agonist indicated in the treatment of cerebrovascular diseases and atherosclerosis. Dihydroergotamine An ergot alkaloid used in the acute treatment of migraine headache and cluster headache. Ergoloid mesylate A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. Dihydroergocornine A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. Metergoline An ergot-derivative that acts as an antagonist at certain 5-HT receptor subtypes and as an agonist at dopamine receptors. It is often used in situations where inhibition of prolactin is desirable. Lisuride For the management of Parkinson's Disease - Drugs & Drug Targets